• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

Share:

June 17, 2020

PRA Health Sciences Inc. (NASDAQ: PRAH) announced today the enhancement of its commercial Health Harmony COVID-19 Monitoring Program with the integration of the Microsoft Healthcare Bot service. Users of PRA’s Health Harmony digital platform who enroll in their organization’s COVID-19 Monitoring Program can use the AI-based chatbot, which can recognize and respond to COVID-19-related questions, to enhance their own COVID-19 care.

Through a series of conversational questions and interactions within PRA’s Health Harmony digital health platform, the COVID-19 chatbot compares users’ symptoms to U.S. Centers for Disease Control guidance and then recommends one of three available COVID-19 programs in which they should enroll. For users of the Health Harmony app, the enrollment experience becomes more personalized and is more accurate in determining the level of COVID-19 care needed. For organizations that have implemented PRA’s COVID-19 Monitoring Program, the integration allows them to understand patient flow and to monitor, educate and individualize care with greater agility.

“Collaborating closely with leading edge companies like Microsoft, PRA is uniquely positioned to deliver innovative new models of care to patients as their needs evolve, especially in times of crisis and uncertainty,” said Kent Thoelke, EVP and Chief Scientific Officer at PRA Health Sciences. “With PRA’s Health Harmony app in their hands, patients can track signs, symptoms and self-manage their own COVID-19-related care, but if symptoms escalate, remote monitoring and the help obtained from a healthcare professional can make all the difference. PRA is giving patients more control and better access to personalized healthcare, right from their own devices and on their own schedule.”

Last month, PRA rolled out the program and the Health Harmony mobile app, with the integration of the COVID-19 Healthcare Bot service, to more than 7,000 employees in the United States. Since March, thousands of users from around the globe have downloaded PRA’s Health Harmony app and enrolled in the COVID-19 Monitoring Program. As part of the program, users can track their own COVID-19 symptoms and educate themselves about the disease. The COVID-19 Monitoring Program – available commercially to employers, payers, providers and health systems – offers three levels of support:

  • The educational program, which provides vital sign tracking, prevention techniques and mental health support for those who are asymptomatic.
  • The quarantine program, which delivers insights on what to watch for, addresses feelings of fear and isolation, and connects with a healthcare professional for those who have been exposed to COVID-19.
  • The in-depth monitoring program, which addresses symptom management, frequent monitoring by a healthcare professional and care coordination for those who have been diagnosed with COVID-19 and who are still at home.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Healthcare and clinical research should be easily accessible to all people and tailored to fit their unique needs,” said Jean Gabarra, General Manager, Health AI at Microsoft. “When technology like Microsoft’s COVID-19 Healthcare Bot and a user-friendly interface like the Health Harmony app can be combined with the insights and expertise of a global healthcare intelligence partner like PRA, patients’ health and wellbeing will benefit tremendously.”

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From SanofiPharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
  • Invitae Sells Reproductive Health Assets to Natera for up to $52.5MInvitae Sells Reproductive Health Assets to Natera for up to $52.5M
  • Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre FoundationHemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation
  • Novo Bolsters Obesity Pipeline with Potential $500M Embark Biotech BuyNovo Bolsters Obesity Pipeline with Potential $500M Embark Biotech Buy
  • Valo Health, Khosla Ventures Terminate Merger Plans at Last MinuteValo Health, Khosla Ventures Terminate Merger Plans at Last Minute
  • Walgreens, FedEx launch prescription delivery nationwideWalgreens, FedEx launch prescription delivery nationwide
  • Atlas Lift Tech Expands to the Arizona Market with the launch of Abrazo Facilities on November 26thAtlas Lift Tech Expands to the Arizona Market with the launch of Abrazo Facilities on November 26th
  • Pharmaceutical Packaging Market to Reach USD 153.93 Billion by 2027 Increasing Technological Advancements and Innovations in Pharmaceutical Packaging Processes to Stimulate Growth, states Fortune Business Insights™Pharmaceutical Packaging Market to Reach USD 153.93 Billion by 2027 Increasing Technological Advancements and Innovations in Pharmaceutical Packaging Processes to Stimulate Growth, states Fortune Business Insights™

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications